Pan.bio
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Pan.bio is a healthcare technology company that provides an AI-powered, end-to-end genomics platform for bioinformatics workflows, variant interpretation, and patient cohort data analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Usage-Based SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pan.bio Comparables
Compare Pan.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rosalind | 79% | |
| Ploid AI | 77% | |
| Basepair Inc | 77% | |
Pan.bio Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Sep 3, 2025
Grew 57% QoQ from 7 to 11 employees.
Pan.bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pan.bio's valuation, stock price, and market status.